Neurogenetic Disorders tests in Dubai & UAE

Compare available Neurogenetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

750.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetic Disorders test prices

Showing 1–15 of 25 matching tests.

Neurogenetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4115 AIFM1 Gene (CMTX4) Genetic Test This genetic test identifies pathogenic variants in the AIFM1 gene associated with X-linked Charcot-Marie-Tooth disease type 4 (CMTX4).	Peripheral whole blood	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AIFM1 gene", "Coding region and intron-exon boundaries of AIFM1"] Parameters [] Preparation [] Indications ["Individuals with suspected CMTX4", "Family members of individuals with CMTX4", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94893-5 ICD-10: G60.0 Clinical summary This genetic test identifies pathogenic variants in the AIFM1 gene associated with X-linked Charcot-Marie-Tooth disease type 4 (CMTX4).
TEST-2637 ARX Gene Lissencephaly (X-linked Type 2) NGS Test This test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly type 2 and related brain malformations.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARX gene pathogenic variants", "Nucleotide substitutions", "Small indels", "Copy number variations"] Parameters [] Preparation [] Indications ["Male infants with lissencephaly", "Infantile spasms", "Developmental delay confirmed by brain MRI"] Measurement technique Confirm with laboratory Codes LOINC: 94243-9 ICD-10: Q04.3 Clinical summary This test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly type 2 and related brain malformations.
TEST-4406 ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test This genetic test identifies pathogenic variants in the ATP1A2 gene associated with Familial Hemiplegic Migraine Type 2.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card	3–4 weeks (from sample receipt at laboratory)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP1A2 gene sequence", "Copy Number Variations (CNVs) in ATP1A2"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected diagnosis of Familial Hemiplegic Migraine Type 2", "Family history of FHM2", "Genetic counseling for migraine disorders"] Measurement technique Confirm with laboratory Codes LOINC: 48000-6 ICD-10: G43.1, G43.10, G43.11 Clinical summary This genetic test identifies pathogenic variants in the ATP1A2 gene associated with Familial Hemiplegic Migraine Type 2.
TEST-5872 ATXN2 Gene Spinocerebellar Ataxia Type 2, Autosomal Dominant Genetic Test This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2).	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansions in the ATXN2 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor."] Indications ["Symptomatic patients", "At-risk family members", "Individuals seeking proactive neurogenetic insight"] Measurement technique Confirm with laboratory Codes LOINC: 38153-2 ICD-10: G11.8 Clinical summary This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2).
TEST-5885 ATXN3 Gene Spinocerebellar Ataxia Type 3 (SCA3) Genetic Test This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3 (SCA3). It provides precise repeat sizin...	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATXN3 gene", "Flanking variants within the ATXN3 gene"] Parameters [{"name": "CAG Repeat Size", "reference_range": "Normal: Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Individuals with clinical symptoms suggestive of SCA3", "Family history of SCA3", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 47528-5 ICD-10: G11.3 Clinical summary This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3 (SCA3). It provides precise repeat sizing and detects flanking variants.
TEST-3849 BPIFA3 Gene Genetic Test for Autism Spectrum Disorder (ASD) This test identifies pathogenic and likely pathogenic variants in the BPIFA3 gene associated with Autism Spectrum Disorder (ASD) susceptibility.	Peripheral Whole Blood	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BPIFA3 gene", "Likely pathogenic variants in the BPIFA3 gene"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of ASD", "Family history of ASD"] Measurement technique Confirm with laboratory Codes LOINC: 81317-3 ICD-10: F84.0 Clinical summary This test identifies pathogenic and likely pathogenic variants in the BPIFA3 gene associated with Autism Spectrum Disorder (ASD) susceptibility.
TEST-4833 CDH15 Gene Mental Retardation, Autosomal Dominant Type 3 (MRD3) Genetic Test This genetic test evaluates the CDH15 gene for pathogenic variants associated with autosomal dominant intellectual disability type 3 (MRD3). It utilizes Next-Generation Sequencing...	Peripheral Whole Blood (preferred) or DNA on FTA Card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CDH15 gene", "Coding region and splice-site boundaries of CDH15"] Parameters [] Preparation [] Indications ["Children and adults presenting with unexplained intellectual disability", "Global developmental delay", "Family history consistent with autosomal dominant inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 104200-5 ICD-10: F78, Q99.8 Clinical summary This genetic test evaluates the CDH15 gene for pathogenic variants associated with autosomal dominant intellectual disability type 3 (MRD3). It utilizes Next-Generation Sequencing (NGS) with Sanger validation for high accuracy.
TEST-5644 CLCN4 Gene Raynaud‑Claes Syndrome Genetic Test This genetic test analyzes the CLCN4 gene for mutations associated with Raynaud‑Claes syndrome.	Peripheral Whole Blood, DNA Extract, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CLCN4 gene sequence", "Pathogenic variants in CLCN4"] Parameters [] Preparation [] Indications ["Suspected Raynaud‑Claes syndrome", "Family history of Raynaud‑Claes syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This genetic test analyzes the CLCN4 gene for mutations associated with Raynaud‑Claes syndrome.
TEST-4818 CTNNB1 Gene Intellectual Disability (Autosomal Dominant 19) Genetic Test This test identifies pathogenic variants in the CTNNB1 gene associated with autosomal dominant intellectual disability type 19.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CTNNB1 gene", "Copy number variants in the CTNNB1 gene"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected autosomal dominant intellectual disability type 19", "Family history of CTNNB1-related intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 21613-4 ICD-10: F78 Clinical summary This test identifies pathogenic variants in the CTNNB1 gene associated with autosomal dominant intellectual disability type 19.
TEST-4890 FOXP1 Gene Sequencing for Intellectual Disability with Language Impairment & Autistic Features (Genetic Test) This test identifies pathogenic variants within the FOXP1 gene, which are associated with specific neurodevelopmental disorders.	Whole Blood (EDTA) or FTA Card; Extracted DNA accepted upon quality review	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FOXP1 gene", "Single nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation ["Pre-test genetic counseling session mandatory", "Construct a three-generation pedigree chart"] Indications ["Unexplained intellectual disability", "Speech delay", "Autistic behaviors", "Suspected FOXP1 syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 101955-1 ICD-10: Q87.89, F78.A9 Clinical summary This test identifies pathogenic variants within the FOXP1 gene, which are associated with specific neurodevelopmental disorders.
TEST-4615 GLRB Gene Hyperekplexia Genetic Test This genetic test analyzes the GLRB gene for variants associated with hereditary hyperekplexia.	Peripheral whole blood (3-5 mL EDTA), extracted DNA (1 µg), or dried blood spot on FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GLRB gene", "Single nucleotide variants", "Insertions", "Deletions"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of hereditary hyperekplexia", "Family history of hyperekplexia", "Neonatal hypertonia and exaggerated startle reflexes"] Measurement technique Confirm with laboratory Codes LOINC: 94480-2 ICD-10: G25.89, Z14.8, E72.8 Clinical summary This genetic test analyzes the GLRB gene for variants associated with hereditary hyperekplexia.
TEST-5757 ITPR1 Gene Spinocerebellar Ataxia Type 15 Genetic Test This test identifies pathogenic variants within the ITPR1 gene associated with Spinocerebellar Ataxia Type 15 (SCA15).	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	21 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITPR1 gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation [] Indications ["Suspected diagnosis of Spinocerebellar Ataxia Type 15 (SCA15)", "Family history of SCA15", "Differential diagnosis of progressive ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 94077-1 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants within the ITPR1 gene associated with Spinocerebellar Ataxia Type 15 (SCA15).
TEST-4602 JPH3 Gene Huntington Disease‑Like 2 (HDL2) Genetic Test This test detects CTG repeat expansions in the JPH3 gene, confirming Huntington disease-like 2 (HDL2).	Whole Blood (EDTA) or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTG repeat expansion in JPH3 gene", "Pathogenic variants associated with HDL2"] Parameters [] Preparation ["Genetic counselling is mandatory before sample collection"] Indications ["Negative Huntington disease (HTT) genetic testing", "Clinical presentation suggestive of HDL2", "Compatible family history"] Measurement technique Confirm with laboratory Codes LOINC: 101452-2 ICD-10: G10 Clinical summary This test detects CTG repeat expansions in the JPH3 gene, confirming Huntington disease-like 2 (HDL2).
TEST-4068 LMNA Gene CMT2B1 Genetic Test This genetic test analyzes the LMNA gene to detect mutations associated with Charcot-Marie-Tooth disease type 2B1, a hereditary neuropathy.	Peripheral Whole Blood (EDTA) or FTA Card (Dried Blood Spots)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LMNA gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)", "Deep intronic variants"] Parameters [] Preparation ["Genetic counselling is mandatory before sample collection.", "A pedigree chart of affected relatives is required."] Indications ["Suspected diagnosis of Charcot-Marie-Tooth disease type 2B1", "Family history of CMT2B1", "Carrier screening in families with known CMT2B1 mutations", "Genetic counseling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94849-5 ICD-10: G60.0 Clinical summary This genetic test analyzes the LMNA gene to detect mutations associated with Charcot-Marie-Tooth disease type 2B1, a hereditary neuropathy.
TEST-4756 LMNB1 Gene (Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy) Genetic Test This genetic test detects duplications in the LMNB1 gene, which are the cause of autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).	Peripheral whole blood (2 × EDTA tubes, 4–6 mL total), extracted genomic DNA, or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LMNB1 gene duplications", "Pathogenic variants in LMNB1"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected diagnosis of ADLD", "Family history of ADLD", "Genetic counseling for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 21636-7 ICD-10: E75.24 Clinical summary This genetic test detects duplications in the LMNB1 gene, which are the cause of autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).

Category overview

Neurogenetic Disorders: overview

Understanding the broader hereditary factors affecting your central and peripheral nervous systems empowers you to manage chronic, overlapping symptoms and make highly informed health decisions. Representing an expansive offering within our advanced Genetics services, testing for Neurogenetic Disorders utilizes comprehensive multi-gene panels to evaluate the complex pathways linked to hereditary spastic paraplegias, leukodystrophies, and familial seizure disorders. Utilizing cutting-edge genomic technology, this robust screening delivers the definitive clarity needed to diagnose complex neurological cases, safely guiding highly customized neurology oversight, proactive physical rehabilitation, and specialized genetic counseling. Consistently ranked among the top diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable reporting. Prioritize your lifelong neurological wellness—book your neurogenetic disorders testing in UAE, arrange a secure clinical sample transfer, or reach out to our dedicated medical genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.